U.S. Office REITs Stock News

In early April 2026, Vertex Pharmaceuticals reported expanded U.S. FDA approvals for its cystic fibrosis therapies ALYFTREK and TRIKAFTA, and completed a rolling Biologics License Application seeking accelerated approval of povetacicept for immunoglobulin A nephropathy in adults using a priority review voucher. These regulatory milestones broaden access to Vertex’s existing cystic fibrosis franchise while pushing the company further into kidney disease, meaningfully reshaping the mix of...

Old Dominion Freight Line (ODFL) is back in focus after surpassing Q4 2025 earnings expectations, maintaining 99% on time performance, and setting a date for its Q1 2026 results release and conference call. See our latest analysis for Old Dominion Freight Line. The recent Q4 2025 earnings beat and consistent 99% on time performance have come alongside a 90 day share price return of 20.93% and a 1 year total shareholder return of 31.12%. This suggests momentum has been building heading into...

Hertz Global Holdings recently reached a proposed non-monetary settlement of a Delaware stockholder derivative and class action related to its Voting Agreement with CK Amarillo, Knighthead, and Certares, with a court hearing scheduled for June 3, 2026. The settlement, which focuses on governance-related amendments rather than cash compensation, highlights how shareholder litigation can reshape control arrangements without directly compensating affected investors. Against this backdrop, we...

In recent weeks, uniQure has come under pressure as the FDA publicly rebuked its disclosures around AMT-130’s pivotal study design, prompting multiple securities class action lawsuits alleging misleading statements about regulatory interactions and Biologics License Application timelines. These disputes cut to the core of uniQure’s credibility on its lead Huntington’s disease gene therapy, raising questions about how accurately management has portrayed the program’s regulatory path to...

Adeia stock overview following recent performance Adeia (ADEA) has attracted fresh attention after a strong price move over the past month. This has put its intellectual property licensing business and current valuation in sharper focus for investors watching US-listed software names. See our latest analysis for Adeia. At a share price of $25.07, Adeia’s recent 26.17% 1 month share price return and very large 5 year total shareholder return indicate that momentum has been building over both...

Gilead Sciences stock after a solid multi year run Gilead Sciences (GILD) continues to attract interest after multi year total returns, including about 34% over the past year and roughly 86% over the past 3 months, that outpaced many large biopharma peers. See our latest analysis for Gilead Sciences. At a share price of US$139.71, Gilead’s recent 7 day share price return of 4.07% and 90 day share price return of 18.10% sit alongside a 1 year total shareholder return of 33.73%. This...

In recent days, Annaly Capital Management has drawn attention as analysts lifted their earnings and revenue expectations while its Onslow Bay subsidiary implemented MeridianLink Mortgage to streamline non-agency whole loan operations. Together, the improved earnings outlook and move to an in-house mortgage origination platform highlight how Annaly is working to strengthen efficiency and potential growth in its core mortgage finance activities. With analysts now projecting higher earnings...

Why USA Rare Earth Stock Is On Investors’ Radar USA Rare Earth (USAR) has drawn attention after a period of mixed share performance, with a 1 day return of 7.6%, a modest gain over the past week, and a decline over the past month. See our latest analysis for USA Rare Earth. That 7.6% 1 day share price return comes after a mixed spell, with a 30 day share price return of 8.8% decline but a year to date share price return of 12.5% and a 1 year total shareholder return of 110.9%. This suggests...

In March 2026, Travel + Leisure Co. completed a US$325 million term securitization through its subsidiary Sierra Timeshare 2026-1 Receivables Funding LLC, issuing multiple classes of asset-backed notes with a weighted average coupon of 5.11% and an advance rate of 98% under a Rule 144A and Regulation S private placement. This securitization highlights the company’s ability to tap asset-backed markets to convert timeshare receivables into funding, potentially strengthening liquidity and...

Boston Scientific (BSX) is under pressure after a sharp sentiment swing, driven by an analyst downgrade tied to slower expectations in U.S. electrophysiology and Watchman, softer guidance, and a series of securities class action filings. See our latest analysis for Boston Scientific. Despite a series of positive trial readouts and new product clearances in recent weeks, sentiment has turned sharply, with a 34.21% 3 month share price decline and a 29.97% 1 year total shareholder return leaving...

Why Boot Barn Holdings (BOOT) Is Back in Focus Boot Barn Holdings (BOOT) recently released financial results that exceeded estimates, supported by higher transaction volumes and new store openings, while also lifting its outlook for the coming year. The stronger performance and updated guidance put the stock back on many investors’ radar, even as some reacted cautiously to management’s comments about near term growth and potential volatility. See our latest analysis for Boot Barn...

HP (HPQ) is back in focus after reporting quarterly revenue of US$14.44b and non GAAP EPS of US$0.81, alongside a broad AI product refresh across PCs, printing, security, and workstations. See our latest analysis for HP. At a share price of US$19.51, HP has seen a 1 day share price return of 2.96%, while the 90 day share price return of a 9.93% decline and the 1 year total shareholder return of a 9.35% decline point to fading momentum despite the recent AI focused product announcements. If...

In recent weeks, Planet Labs PBC expanded its Berlin manufacturing facility plan to double production of its next-generation Pelican satellites, supported by a US$900 million backlog, new satellite deployments, and increased investment in AI-powered analytics and in-space computing partnerships. The combination of expanded European capacity, government-backed contracts from Germany and Sweden, and AI-focused collaborations positions Planet Labs more firmly in higher-value Earth observation...

Market relief rally puts Under Armour (UAA) back in focus Under Armour (UAA) moved higher following broader market optimism, as investors reacted to potential easing of hostilities in Iran and Federal Reserve comments indicating that inflation appears contained and interest rates may remain stable. See our latest analysis for Under Armour. The latest move comes after a choppy few months, with a 30 day share price return of a 14.72% decline, contrasting with a 90 day share price return of a...

In early April 2026, Oruka Therapeutics, Inc. filed an omnibus shelf registration that would allow it to issue up to US$1 billion of common stock, preferred stock, depositary shares, and warrants over time. This broad financing framework gives Oruka Therapeutics flexible access to multiple types of capital, which could be used for future clinical, operational, or transactional initiatives. Next, we’ll examine how this flexible US$1 billion shelf registration may influence Oruka Therapeutics’...

Why the latest earnings matter for Arcos Dorados Holdings (ARCO) Arcos Dorados Holdings (ARCO) is back in focus after fourth quarter results came in below expectations, with EBITDA and net income missing forecasts and an adjusted net loss catching many investors’ attention. At the same time, the board authorized a 2026 cash dividend totaling US$0.28 per share in four equal installments, giving shareholders a clearer view of planned capital returns even as they assess the recent earnings...

Dividend increase and capital returns in focus CSW Industrials (CSW) declared a regular quarterly cash dividend of US$0.30 per share, an increase of US$0.03 or about 11%, along with fourth quarter share repurchases of approximately US$34.9 million. See our latest analysis for CSW Industrials. CSW Industrials’ recent 11% dividend increase and share repurchases follow a 1-year share price return that is close to flat, with a total shareholder return of 0.17%. However, longer-term total...

Viking Therapeutics recently announced it has completed patient enrollment in VANQUISH-2, its Phase 3, 78-week trial of once-weekly subcutaneous VK2735 in about 1,000 adults with type 2 diabetes who are obese or overweight. This milestone moves Viking’s lead dual GLP-1/GIP agonist closer to pivotal data in obesity and diabetes, building directly on prior Phase 2 VENTURE results showing clinically meaningful weight loss and an encouraging safety profile. We’ll now examine how completing...

In early April 2026, Donnelley Financial Solutions President Eric J. Johnson disclosed an open‑market sale of 20,280 shares, worth about US$1,000,000, in an SEC Form 4 filing, reducing his direct holding to 87,473 shares. This was his largest open‑market sale since June 2024 and, because it was not executed under a pre‑planned trading arrangement, it may raise fresh questions among investors about insider confidence and timing. We’ll now examine how this large, non‑planned insider sale could...

Setting the scene for Hub Group after recent performance Recent share performance for Hub Group (HUBG) has been mixed, with a 3.2% gain over the past week contrasting with declines over the past month and past 3 months. This has prompted closer attention from investors. See our latest analysis for Hub Group. The recent 3.2% 7 day share price return sits against a weaker 30 day and 90 day share price performance. The 1 year total shareholder return of 10.88% points to momentum that has been...

Peabody Energy (BTU) has drawn fresh attention after cutting first quarter sales expectations for its Centurion Mine due to commissioning challenges, while still keeping full year metallurgical coal volume guidance unchanged. See our latest analysis for Peabody Energy. The Centurion update landed after a sharp single day sell off of around 10% and follows other weak sessions, contributing to a 15.0% 7 day share price decline. However, the 90 day share price return of 9.6% and very large 5...

QUALCOMM (QCOM) is back in focus after a mixed run of analyst opinions, a new US$20b share buyback, a higher quarterly dividend, and fresh volatility tied to geopolitical pressure on chip stocks. See our latest analysis for QUALCOMM. The recent analyst debate, fresh buyback announcement and geopolitical jitters around chip names have come against a weaker price backdrop, with a 90 day share price return of a 28.08% decline but a 1 year total shareholder return of 1.81%, indicating that longer...

Why the Niagen partnership matters for OneSpaWorld OneSpaWorld Holdings (OSW) is back in focus after Niagen Bioscience engaged the company to offer pharmaceutical grade Niagen IV across more than 80 Medi-Spa clinics onboard high end cruise ships. This agreement broadens OneSpaWorld's wellness menu while tying into a larger clinical network, and comes as the stock recently formed a golden cross technical pattern alongside upward revisions to earnings projections. See our latest analysis for...

In its recent quarterly update, Ladder Capital Corp reported US$50.47 million in revenue, around a 26.4% year-on-year decline and below analyst expectations, alongside a miss on tangible book value per share estimates. This combination of weaker-than-expected revenue and tangible book value highlights pressure on both Ladder Capital’s income generation and balance-sheet performance versus peers. Next, we’ll examine how this earnings and tangible book value shortfall may affect Ladder...